Indoleamine 2,3-Dioxygenase 1 (IDO1) Is Up-Regulated in Thyroid Carcinoma and Drives the Development of an Immunosuppressant Tumor Microenvironment

Sonia Moretti, Elisa Menicali, Pasquale Voce, Silvia Morelli, Sara Cantarelli, Marialuisa Sponziello, Renato Colella, Francesca Fallarino, Ciriana Orabona, Alessia Alunno, Dario de Biase, Vittorio Bini, Maria Grazia Mameli, Sebastiano Filetti, Roberto Gerli, Antonio Macchiarulo, Rosa Marina Melillo, Giovanni Tallini, Massimo Santoro, Paolo Puccetti, Nicola Avenia, Efisio Puxeddu
  • The Journal of Clinical Endocrinology & Metabolism, May 2014, Endocrine Society
  • DOI: 10.1210/jc.2013-3351

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1210/jc.2013-3351

The following have contributed to this page: Professor FRANCESCA FALLARINO and ANTONIO MACCHIARULO